HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples. Issue 48 (27th November 2015)
- Record Type:
- Journal Article
- Title:
- HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples. Issue 48 (27th November 2015)
- Main Title:
- HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples
- Authors:
- van der Put, Robert M.F.
de Haan, Alex
van den IJssel, Jan G.M.
Hamidi, Ahd
Beurret, Michel - Abstract:
- Highlights: Hib fermentation (USP) and purification (DSP) products were analyzed by HPAEC-PAD. Colorimetric methods are not sufficiently accurate. Correlation between HPAEC-PAD and orcinol data was high for DSP samples. The HPAEC-PAD method has the advantage of giving a specific PRP response. Medium components from the early part of the fermentation interfered with the analyses. Abstract: Due to the rapidly increasing introduction of Haemophilus influenzae type b (Hib) and other conjugate vaccines worldwide during the last decade, reliable and robust analytical methods are needed for the quantitative monitoring of intermediate samples generated during fermentation (upstream processing, USP) and purification (downstream processing, DSP) of polysaccharide vaccine components. This study describes the quantitative characterization of in-process control (IPC) samples generated during the fermentation and purification of the capsular polysaccharide (CPS), polyribosyl-ribitol-phosphate (PRP), derived from Hib. Reliable quantitative methods are necessary for all stages of production; otherwise accurate process monitoring and validation is not possible. Prior to the availability of high performance anion exchange chromatography methods, this polysaccharide was predominantly quantified either with immunochemical methods, or with the colorimetric orcinol method, which shows interference from fermentation medium components and reagents used during purification. Next to an improved highHighlights: Hib fermentation (USP) and purification (DSP) products were analyzed by HPAEC-PAD. Colorimetric methods are not sufficiently accurate. Correlation between HPAEC-PAD and orcinol data was high for DSP samples. The HPAEC-PAD method has the advantage of giving a specific PRP response. Medium components from the early part of the fermentation interfered with the analyses. Abstract: Due to the rapidly increasing introduction of Haemophilus influenzae type b (Hib) and other conjugate vaccines worldwide during the last decade, reliable and robust analytical methods are needed for the quantitative monitoring of intermediate samples generated during fermentation (upstream processing, USP) and purification (downstream processing, DSP) of polysaccharide vaccine components. This study describes the quantitative characterization of in-process control (IPC) samples generated during the fermentation and purification of the capsular polysaccharide (CPS), polyribosyl-ribitol-phosphate (PRP), derived from Hib. Reliable quantitative methods are necessary for all stages of production; otherwise accurate process monitoring and validation is not possible. Prior to the availability of high performance anion exchange chromatography methods, this polysaccharide was predominantly quantified either with immunochemical methods, or with the colorimetric orcinol method, which shows interference from fermentation medium components and reagents used during purification. Next to an improved high performance anion exchange chromatography-pulsed amperometric detection (HPAEC-PAD) method, using a modified gradient elution, both the orcinol assay and high performance size exclusion chromatography (HPSEC) analyses were evaluated. For DSP samples, it was found that the correlation between the results obtained by HPAEC-PAD specific quantification of the PRP monomeric repeat unit released by alkaline hydrolysis, and those from the orcinol method was high ( R 2 = 0.8762), and that it was lower between HPAEC-PAD and HPSEC results. Additionally, HPSEC analysis of USP samples yielded surprisingly comparable results to those obtained by HPAEC-PAD. In the early part of the fermentation, medium components interfered with the different types of analysis, but quantitative HPSEC data could still be obtained, although lacking the specificity of the HPAEC-PAD method. Thus, the HPAEC-PAD method has the advantage of giving a specific response compared to the orcinol assay and HPSEC, and does not show interference from various components that can be present in intermediate and purified PRP samples. … (more)
- Is Part Of:
- Vaccine. Volume 33:Issue 48(2015)
- Journal:
- Vaccine
- Issue:
- Volume 33:Issue 48(2015)
- Issue Display:
- Volume 33, Issue 48 (2015)
- Year:
- 2015
- Volume:
- 33
- Issue:
- 48
- Issue Sort Value:
- 2015-0033-0048-0000
- Page Start:
- 6908
- Page End:
- 6913
- Publication Date:
- 2015-11-27
- Subjects:
- CPS capsular polysaccharide -- DSP downstream processing -- ESTD external standard -- Glc glucose -- Glc-6-P d-glucose-6-phosphate -- Hib Haemophilus influenzae type b -- HPAEC-PAD high performance anion exchange chromatography with pulsed amperometric detection -- HPSEC high performance size exclusion chromatography -- IPC in process control -- kDa kilo Dalton -- μRIU micro-refractive index unit -- Mw absolute weight-average molecular mass -- MWCO molecular weight cut-off -- NA nucleic acids -- NaAc sodium acetate -- NaOH sodium hydroxide -- OD optical density -- PBS phosphate buffered saline -- PRP polyribosyl-ribitol-phosphate (Hib CPS) -- Rib d(−)-ribose -- RI refractive index -- RIVM National Institute for Public Health and the Environment -- RU repeating unit(s) of the polysaccharide -- tR retention time -- USP upstream processing -- WFI water for injection -- WHO World Health Organization
Anion exchange chromatography -- Bacterial polysaccharides analysis -- Downstream processing -- High pressure liquid chromatography -- Polysaccharide -- Upstream processing
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2014.07.028 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4919.xml